Vivos
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Colorado, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
9135 Ridgeline Blvd Ste 100, Highlands R...Phone Number
(720) 399-9322Website
www.vivos.comRevenue
$19.6 MillionStock Symbol
VVOSIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Vivos
Vivos Therapeutics Inc. is a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep disordered breathing, including mild to moderate obstructive sleep apnea (OSA). Vivos believes that its Vivos System technology represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective alternative for people with mild-to-moderate OSA. Combining technologies and protocols that can alter the size, shape and position of the tissues of the upper human airway, the Vivos System opens airway space and can significantly reduce symptoms and conditions associated with mild-to-moderate OSA. The Vivos System has been shown to significantly lower Apnea Hypopnea Index scores and improve other conditions associated with OSA. Sales of the Vivos System are driven by the independent dentists enrolled in the Vivos Integrated Practice (VIP) program, which offers dentists training and value-added servicesRead more
Vivos Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vivos your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Vivos launches new products
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Vivos
Earning: See what the market has to say on Vivos recently announced quarterly report
Funding: Get notified immidiatlly once Vivos has new funding data
Check if Vivos has recently received funding, and reach out quickly before it becomes old news!
Vivos, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Vivos is spiking on competitors!
Click to see if Vivos had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Vivos
Find 3 more new buyers
Compare Similar Companies to Vivos
Compare insights from companies similar to Vivos, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$730.2M
1K - 5K
Public
$425M
2009
DA
Dominic AlloccoVice President, Clinical Affairs & Associate Chief Medical Officer
Company Profile Activity
Activity Insights
Vivos is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Vivos is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Vivos.
Vivos financials insights
Gather financial insights about Vivos, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$1M
Stock Offering
$21M
Vivos Tech Stack
A closer look at the technologies used by Vivos
Most Recent Scoops
Person-Based
Partnership, Corporate Strategy
Person-Based
Partnership
Person-Based
Earnings, Acquisitions, Finance
Earnings
Earnings, Finance
Earnings
Earnings, Finance
Vivos News & Media
Vivos’ Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants
Vivos’ Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study ParticipantsVivos Therapeutics Enters Debt-for-Equity Deal, Extends $2.6M Financing Deadline With Streeterville
Vivos Therapeutics entered a debt-for-equity Exchange Agreement with Streeterville Capital on June 5, 2026, converting a portion of its debt into preferred and common stock to reduce leverage and enhance liquidity. Subsequently, on June 18, 2026, the parties executed a Letter Agreement extending th…Vivos Therapeutics and Streeterville Extend Timeframe of - GlobeNewswire
Vivos and Streeterville Extend Timeframe of Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity...Vivos extends Streeterville financing to Aug. 31 | VVOS Stock News
Streeterville extended the financing timeframe to Aug. 31, 2026, and kept its plan to convert up to $4.5M of debt into preferred and common stock.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vivos
Sign Up For FreeTo access detailed company insights
Vivos Therapeutics Inc. is a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep disordered breathing, including mild to moderate obstructive sleep apnea (OSA). Vivos believes that its Vivos System technology represents the first clinically effective non-surgical, non-invasive... Read More
